Loading clinical trials...
Loading clinical trials...
Currently, patients with a glioblastoma multiforme (GBM) are treated with a combination of different therapeutic modalities including resection, concurrent chemo- and radiotherapy and adjuvant temozol...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Maastricht Radiation Oncology
Collaborators
NCT07003542 · Glioblastoma, Brain Tumor
NCT05902169 · Glioblastoma, Recurrent Glioblastoma, and more
NCT05303467 · Glioblastoma Multiforme, Recurrent Glioblastoma
NCT07464925 · Glioblastoma Multiforme of Brain, Glioma, and more
NCT07274397 · Glioblastoma, Brain Tumors, and more
Maastricht Radiation Oncology (MAASTRO clinic)
Maastricht, Limburg
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions